课题基金 / 基金详情

项目摘要

项目成果

Igor S. Lukashevich的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Arenaviruses are rodent-borne viruses that cause fatal illness when transmitted to man. Lassa fever virus in Africa and Machupo virus in Bolivia are two arenaviruses that have caused noteable outbreaks in the last few years. The prototype arenavirus, lymphocytic choriomeningitis virus (LCMV), has frequently been used to study cell-mediated immunity in inbred mice. However murine infection is an inappropriate model for arenavirus disease in man, because human disease is more virulent and has a different pathogenic mechanism. Furthemore, experimental infections have employed primarily parenteral routes of inoculation, and mucosal inoculation (through inhalation or ingestion) is the most frequent natural route of infection. Studies with other viral systems, particularly the monkey model for AIDS, illustrate that the route of inoculation profoundly influences the pathogenesis and immune responses to infection. Since little is known about arenavirus infection after mucosal inoculation, we propose a pilot study to extend our murine mucosal studies to the nonhuman primate. After intragastric inoculation of rhesus macaques we will collect information about the level and distribution of virus, the timecourse of immune responses, and the progression of pathology. We will employ LCMV infection of monkeys, which strongly resembles Lassa fever virus infection of monkeys. We will test the hypothesis that mucosal LCMV infection of the rhesus macaque shares several features of murine mucosal LCMV infection, but differs fundamentally in pathogenesis. The information we collect will be important for human disease and for diseases affecting nonhuman primates (e.g., callitriched hepatitis, an emerging disease of captive New World primates). The information about immune response timecourse will provide landmarks for vaccine-elicited immune responses. Thus, this information will serve as the basis for developing mucosal vaccines and pharmacological treatments that target mucosal arenavirus infections.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1586/erv.12.139
发表时间: 2013-01
期刊: Expert review of vaccines
影响因子: 6.2
作者: [Lukashevich IS]
通讯作者: Lukashevich IS
Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.
灵长类动物的粘膜沙粒病毒感染可以保护它们免受致命的出血热。
DOI: 10.1002/jmv.20000
发表时间: 2004
期刊: Journal of medical virology
影响因子: 12.7
作者: [Rodas,JuanD, Lukashevich,IgorS, Zapata,JuanC, Cairo,Cristiana, Tikhonov,Ilia, Djavani,Mahmoud, Pauza,CDavid, Salvato,MariaS]
通讯作者: Salvato,MariaS
Development of New Bivalent Cross-Protective Arenaviral Vaccines
  • 批准号:
    8249031
  • 项目类别:
  • 资助金额:
    $82.27万
  • 财政年份:
    2011
  • 负责人:
    Igor S. Lukashevich
  • 依托单位:
Development of New Bivalent Cross-Protective Arenaviral Vaccines
  • 批准号:
    8076666
  • 项目类别:
  • 资助金额:
    $12.21万
  • 财政年份:
    2011
  • 负责人:
    Igor S. Lukashevich
  • 依托单位:
Development of New Bivalent Cross-Protective Arenaviral Vaccines
  • 批准号:
    8389370
  • 项目类别:
  • 资助金额:
    $74.59万
  • 财政年份:
    2011
  • 负责人:
    Igor S. Lukashevich
  • 依托单位:
Development of New Bivalent Cross-Protective Arenaviral Vaccines
  • 批准号:
    8649000
  • 项目类别:
  • 资助金额:
    $72.77万
  • 财政年份:
    2011
  • 负责人:
    Igor S. Lukashevich
  • 依托单位:
海外基金